A new role for IDH1 in the control of ovarian cancer cells metabolism and senescence
Open Access
- 1 June 2020
- journal article
- editorial
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 8 (12) , 780
Abstract
A new role for IDH1 in the control of ovarian cancer cells metabolism and senescenceKeywords
This publication has 20 references indexed in Scilit:
- Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian CancerMolecular Cancer Research, 2019
- USP1 links platinum resistance to cancer cell dissemination by regulating Snail stabilityScience Advances, 2019
- Wild-Type IDH Enzymes as Actionable Targets for Cancer TherapyCancers, 2019
- Ovarian cancer statistics, 2018CA: A Cancer Journal for Clinicians, 2018
- SASP: Tumor Suppressor or Promoter? Yes!Trends in Cancer, 2016
- Ovarian cancerNature Reviews Disease Primers, 2016
- Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxiaNature, 2011
- Evolution of platinum resistance in high-grade serous ovarian cancerThe Lancet Oncology, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- JmjC-domain-containing proteins and histone demethylationNature Reviews Genetics, 2006